Nanotechnology plays a crucial role in enhancing Onivyde by utilizing nanocarriers to encapsulate the active drug. These nanocarriers, which are typically liposomes, protect the drug from premature degradation and enable a controlled release. The small size of these nanocarriers allows them to pass through biological barriers more efficiently, targeting cancer cells with higher precision and reducing the impact on healthy tissues.
